ML Bolognesi; M Rosini; A Minarini; V Tumiatti; A Cavalli; M Bartolini; V Andrisano; R Fato; C Bergamini; C Melchiorre, Rational design of multitarget-directed antioxidants: merging memoquin and lipocrine molecular frameworks, in: Final Program and Poster Abstractsfor the 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, s.l, s.n, 2010, pp. 93 - 93 (atti di: 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, Geneva, Switzerland, March, 24-27, 2010) [atti di convegno-abstract]
Tran HNA; Bongarzone S ; Carloni P; Legname G ; Bolognesi ML, Synthesis and evaluation of a library of 2,5-bisdiamino-benzoquinone derivatives as probes to modulate protein-protein interactions in prions, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2010, 20, pp. 1866 - 1868 [articolo]
Minarini A.; Milelli A.; Tumiatti V.; Rosini M.; Bolognesi M.L.; Melchiorre C., Synthetic polyamines: an overview of their multiple biological activities., «AMINO ACIDS», 2010, 38, pp. 383 - 392 [articolo]
Tumiatti V.; Minarini A.; Bolognesi M.L.; Milelli A.; Rosini M.; Melchiorre C., Tacrine Derivatives and Alzheimer's Disease, «CURRENT MEDICINAL CHEMISTRY», 2010, 17, pp. 1825 - 1838 [articolo]
Bolognesi M.L.; Matera R.; Minarini A.; Rosini M.; Melchiorre C., Alzheimer's disease: new approaches to drug discovery., «CURRENT OPINION IN CHEMICAL BIOLOGY», 2009, 13, pp. 303 - 308 [articolo]
Kranjc A.; Bongarzone S.; Rossetti G.; Biarnes X.; Cavalli A.; Bolognesi M. L.; Roberti M.; Legname G.; Carloni P., Docking ligands on protein surfaces: the case study of prion protein., «JOURNAL OF CHEMICAL THEORY AND COMPUTATION», 2009, 5, pp. 2565 - 2573 [articolo]
Mancini F.; Bolognesi M.L.; Melchiorre C.; Andrisano V., Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of
Alzheimer's disease., «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2009, 50(2), pp. 164 - 170 [articolo]
Bolognesi ML; Cavalli A; Melchiorre C., Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease, «NEUROTHERAPEUTICS», 2009, 6, pp. 152 - 162 [articolo]
Bolognesi M.L.; Rosini M.; Andrisano V.; Bartolini M.; Minarini A.; Tumiatti V.; Melchiorre C., MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond, «CURRENT PHARMACEUTICAL DESIGN», 2009, 15, pp. 601 - 613 [articolo]
M. Rosini; M. Bartolini; E. Simoni; C. Gotti; D. McClymont; ML Bolognesi; A. Minarini; V. Tumiatti; V. Andrisano; I. R. Mellor; C. Melchiorre, Multi-Target-Direcetd Ligands as acetylcholinesterase inhibitors and nicotinic modulators for Alzheimer's disease, in: , «DRUGS OF THE FUTURE», 2009, 34, pp. 195 - 195 (atti di: Frontiers in medicinal chemistry: Emerging targets, novel candidates and innovative strategies, Barcelona, October, 4-6, 2009) [atti di convegno-abstract]
M. L. Bolognesi, Multi-target-directed ligands as an innovative therapeutic opportunity for Alzheimer's disease, in: Meeting Program-Abstract Book, s.l, s.n, 2009, pp. 42 - 43 (atti di: 6th International Winter Conference on Alzheimer's Disease: “Why do we have so few Drugs for Treatment of Alzheimer’s Disease –wrong Patients, wrong Targets, wrong Drugs?“ A critical discussion, Zuers, Austria, Saturday, 5th of December to Tuesday, 8th of December 2009) [Contributo in Atti di convegno]
Cavalli A; Bolognesi ML, Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania, «JOURNAL OF MEDICINAL CHEMISTRY», 2009, 52, pp. 7339 - 7359 [articolo]
Brevetto n. WO 2009034457, Organic compounds useful for the treatment of neurodegenerative diseases, uses and methods for the preparation thereof.
A. Minarini; V. Tumiatti; M.L. Bolognesi; M. Rosini; C. Melchiorre, Polymethylene tetraamine backbone as template for the development of biologically active polyamines, in: Biogenic amines: biochemical, physiological and clinical aspects, s.l, s.n, 2009, pp. 14 - 14 (atti di: Biogenic amines: biochemical, physiological and clinical aspects, Bertinoro (FC, Italy), 11-14, 2009) [atti di convegno-abstract]
Brevetto n. US 7,589,219 B2, Preparation of 2,5-bis-diamine-[1,4]benzoquinone derivatives for the treatment of Alzheimer's disease and a process for their preparation and intermediates thereof..
